We are live on ! Find out more
DMAA

Drugs Made In America Acquisition Corp
DMAA

18 hedge funds and large institutions have $103M invested in Drugs Made In America Acquisition Corp in 2026 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 12 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

27.26% less ownership

Funds ownership: 68.23% → 40.98% (-27%)

54% less funds holding

Funds holding: 39 → 18 (-21)

56% less capital invested

Capital invested by funds: $237M → $103M (-$134M)

75% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 12

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 14

Holders
18
Holders Change
-21
Holders Change %
-53.85%
% of All Funds
0.22%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
–
Increased
3
Reduced
12
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MSU
Mizuho Securities USA
New York
+$737K
2
CS
Clear Street
New York
+$301K
3
JP Morgan Chase
JP Morgan Chase
New York
+$106

Top Sellers

Rank Fund Capital Flow
1
FTCM
First Trust Capital Management
Illinois
-$15.4M
2
WCMNY
Westchester Capital Management (New York)
New York
-$11.5M
3
WAM
Wolverine Asset Management
Illinois
-$7.64M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$7.25M
5
SCM
Shaolin Capital Management
Florida
-$5.76M
Name Holding Trade Value Shares
Change 		Change in
Stake
KIM
1
Karpus Investment Management
New York
$26.7M -$240K -22,700 -0.9%
MSU
2
Mizuho Securities USA
New York
$21.9M +$737K +69,605 +3%
PAMP
3
Polar Asset Management Partners
Ontario, Canada
$12.2M -$4.81M -454,000 -28%
WAM
4
Wolverine Asset Management
Illinois
$8.86M -$7.64M -721,615 -46%
FTCM
5
First Trust Capital Management
Illinois
$8.38M -$15.4M -1,456,041 -65%
HCM
6
Heights Capital Management
California
$6.9M -$20.3K -1,917 -0.3%
WCMNY
7
Westchester Capital Management (New York)
New York
$6.2M -$11.5M -1,087,210 -65%
AC
8
Aristeia Capital
Connecticut
$3.73M -$5.63M -531,716 -60%
SAMU
9
SONA Asset Management (US)
New York
$1.73M – – –
CS
10
Clear Street
New York
$1.65M +$301K +28,392 +8%
RC
11
RLH Capital
New York
$1.23M -$2.13M -200,945 -63%
Toronto Dominion Bank
12
Toronto Dominion Bank
Ontario, Canada
$1.06M -$1.1M -103,838 -51%
MC
13
Meteora Capital
Florida
$1.04M -$2.99M -282,462 -74%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$663K – – –
JP Morgan Chase
15
JP Morgan Chase
New York
$531K +$106 +10 +0%
DWM
16
Dakota Wealth Management
Florida
$388K – – –
HF
17
HRT Financial
New York
$196K -$95.3K -9,004 -33%
Morgan Stanley
18
Morgan Stanley
New York
$298 -$318 -30 -52%
D.E. Shaw & Co
19
D.E. Shaw & Co
New York
– -$7.25M -690,000 Closed
SCM
20
Shaolin Capital Management
Florida
– -$5.76M -550,000 Closed
RCM
21
Radcliffe Capital Management
Pennsylvania
– -$5.74M -546,808 Closed
LP
22
LMR Partners
United Kingdom
– -$5.24M -500,000 Closed
WA
23
Whitebox Advisors
Minnesota
– -$4.19M -400,000 Closed
CCM
24
Context Capital Management
California
– -$2.62M -250,000 Closed
GL
25
Governors Lane
New York
– -$2.62M -250,000 Closed
1
2

DMAA Hedge Fund Activity: Q2 2026 in Review

18 of the 8,153 institutional investors tracked by Wall St. Rank reported a position in Drugs Made In America Acquisition Corp (DMAA) for Q2 2026, worth a combined $103M — down 56% from $237M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of DMAA and 0 opened new positions — a net loss of 14 holders — while 12 trimmed existing stakes and 3 added.

The largest buyer was Mizuho Securities USA, adding an estimated $737K. The largest seller was First Trust Capital Management, cutting an estimated $15.4M.

  • 18 institutional investors held Drugs Made In America Acquisition Corp (DMAA) as of Q2 2026, down from 39 in Q1 2026.
  • Funds reported $103M of Drugs Made In America Acquisition Corp stock for Q2 2026, down 56% quarter-over-quarter.
  • 0 funds opened new Drugs Made In America Acquisition Corp positions in Q2 2026 and 14 closed out, a net change of -14 holders.
  • The largest Drugs Made In America Acquisition Corp buyer in Q2 2026 was Mizuho Securities USA, an estimated $737K added.
  • The largest Drugs Made In America Acquisition Corp seller in Q2 2026 was First Trust Capital Management, an estimated $15.4M sold.

Based on aggregated 13F filings for Q2 2026.